1,7-phenanthroline has been researched along with Angiogenesis, Pathologic in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, GD; Kim, S; Lee, SK; Oh, J | 1 |
Cao, ZY; Li, G; Ma, XT; Rao, Q; Wu, KF; Zhang, B; Zheng, GG | 1 |
Kurschat, P; Löffek, S; Mauch, C; Smola, H; Steiger, J; Zigrino, P | 1 |
Carmona, AK; Juliano, L; Juliano, MA; Monteiro, HP; Oliveira, V; Paschoalin, T; Rodrigues, EG; Travassos, LR | 1 |
Montesano, R; Orci, L | 1 |
5 other study(ies) available for 1,7-phenanthroline and Angiogenesis, Pathologic
Article | Year |
---|---|
Antofine, a natural phenanthroindolizidine alkaloid, suppresses angiogenesis via regulation of AKT/mTOR and AMPK pathway in endothelial cells and endothelial progenitor cells derived from mouse embryonic stem cells.
Topics: AMP-Activated Protein Kinases; Angiogenesis Inhibitors; Animals; Cell Proliferation; Endothelial Progenitor Cells; Humans; Indoles; Indolizines; Mice; Mouse Embryonic Stem Cells; Neovascularization, Pathologic; Phenanthrolines; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A | 2017 |
IL-18 increases invasiveness of HL-60 myeloid leukemia cells: up-regulation of matrix metalloproteinases-9 (MMP-9) expression.
Topics: Antibodies, Monoclonal; Cell Movement; Extracellular Matrix; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Interleukin-18; Leukemia, Myeloid; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Neovascularization, Pathologic; Phenanthrolines; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-1; Up-Regulation | 2004 |
Melanoma cell-derived vascular endothelial growth factor induces endothelial tubulogenesis within fibrin gels by a metalloproteinase-mediated mechanism.
Topics: Endothelium, Vascular; Fibrin; Gels; Humans; Melanoma; Metalloendopeptidases; Metalloproteases; Neovascularization, Pathologic; Phenanthrolines; Protease Inhibitors; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2006 |
Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth.
Topics: Angiogenic Proteins; Animals; Antineoplastic Agents; Bradykinin; Cell Extracts; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cloning, Molecular; Coculture Techniques; Collagen; Culture Media, Conditioned; Dipeptides; Dose-Response Relationship, Drug; Drug Combinations; Endothelial Cells; Female; Hydrolysis; Laminin; Leucine; Melanoma, Experimental; Metalloendopeptidases; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Neurotensin; Nitric Oxide; Nitric Oxide Donors; Oligopeptides; Peptides; Phenanthrolines; Protease Inhibitors; Proteoglycans; S-Nitroso-N-Acetylpenicillamine; Substrate Specificity | 2007 |
Tumor-promoting phorbol esters induce angiogenesis in vitro.
Topics: Animals; Capillaries; Cattle; Cell Count; Cell Line; Cell Movement; Collagen; DNA; Endothelium; Microbial Collagenase; Neovascularization, Pathologic; Phenanthrolines; Phorbol Esters; Phorbols; Plasminogen Activators; Protease Inhibitors; Protein Biosynthesis; Tetradecanoylphorbol Acetate | 1985 |